Delayed haemolytic transfusion reaction (DHTR) is a potentially life‐threatening
complication of red blood cell (RBC) transfusions in sickle cell disease (SCD) and is …

Delayed hemolytic transfusion reactions (DHTR) occurring in individuals with sickle cell
disease (SCD) are usually indolent but may rarely progress to life-threatening hemolysis …

BACKGROUND Patients with sickle cell disease (SCD) often require red blood cell (RBC)
transfusions but alloimmunization remains a significant complication. Alloantibodies can …

BACKGROUND Delayed hemolytic transfusion reactions (DHTRs) are serious complications
of RBC transfusion that can occur in previously alloimmunized patients. Patients who require …

Red blood cell (RBC) transfusion therapy is a key component in the comprehensive
management of patients with sickle cell disease (SCD). Consequently, most adult SCD …

Delayed haemolytic transfusion reactions (DHTR) are potentially life‐threatening
complications in patients with sickle cell disease (SCD). Between 1 August 2008 and 31 …

Transfusion remains a key treatment of sickle cell disease complications. However, delayed
hemolytic transfusion reaction, the most serious complication of transfusion, may be life …

Transfusion therapy is effective in the prevention and treatment of many complications of
sickle cell disease (SCD). However, its benefits must be balanced against its risks, including …

Transfusion of red blood cells (RBC) remains a primary treatment modality in patients with
sickle cell disease (SCD). Repeated exposure to alloantigens on transfused RBCs can lead …

Background Delayed haemolytic transfusion reaction (DHTR) is mainly caused by an
immune response to transfused red blood cells (RBC s). Immunized patients have a high …